| 名稱 | ERBB4 E452K （NRG1b Dependent）/BaF3 |
| 型號(hào) | CBP73258 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | ERBB4 E452K （NRG1b Dependent）/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- PD-1阻斷療法激活的T細(xì)胞還需依賴CD28共刺激
- 一個(gè)好的ATCC細(xì)胞株有多方面要求
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- 有關(guān)腫瘤細(xì)胞的基因突變研究講解
- ATCC細(xì)胞的貼壁過程有何特點(diǎn)呢？
- IL2細(xì)胞篩選模型
- 【靶點(diǎn)模型+診斷質(zhì)控】BCR-ABL1的藥物開發(fā)和診斷
- *針對肝癌的PD-1抗體獲FDA批準(zhǔn)，國產(chǎn)PD-1抗體進(jìn)入三期
- Cell Metab：雙信號(hào)通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 【連載-企業(yè)參考品】胃癌的診斷參考品的選擇
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73258ERBB4 E452K （NRG1b Dependent）/BaF3
- 詳細(xì)內(nèi)容
| CBP73258 | |
| I. Introduction | |
Cell Line Name： | ERBB4 E452K (NRG1b Dependent)/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+10ng/ml NRG1-beta1 |
Mycoplasma Status: | Negative |
| II.Background | |
Human HER4 kinase, also known as Erb-B4, Proto-Oncogene-Like Protein C-ErbB-4, and Tyrosine Kinase-Type Cell Surface Receptor HER4, GenBank Accession No. NM_005235, a.a. 708-993, with an N-terminal GST-tag, expressed in a Baculovirus infected Sf9 cell expression system. MW=59.5 kDa. | |
| III. Representative Data | |
1.ERBB4 E452K (NRG1b Dependent)/BaF3
| |
2. Anti-proliferation assay
Figure 2. Anti-proliferation assay of two reference compounds on the ERBB4 E452K (NRG1b Dependent)/BaF3 Stable Cell line. | |
員_a.png)